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Th1 responsea b s t r a c t
Paracoccidiodomycosis is a systemic mycosis caused by the fungus Paracoccidioides brasiliensis (Pb),
which is endemic in Latin America. The host innate immune response against the fungus has been well
characterized and several studies have shown the important role played by phagocytic cells. Our
laboratory has studied the relationship between human neutrophils (PMNs)/Pb, focusing the effector
mechanisms of these cells against the fungus. However, in last years, studies have shown that in addition
to their phagocytic and killer functions, PMNs can modulate and instruct the immune response, since
these cells have been shown to produce and release several cytokines. Thus, we evaluated whether PMNs
stimulated with Pb can modulate the immune response to a Th1 phenotype through the production of
IFN-c, as well as the role of ‘‘pattern-recognition receptors’’ (PRRs) such as TLR2, TLR4 and Dectin-1 in
this production. Furthermore, we asked whether activation of the cells with the cytokines IL-12, IL-15
and IL-18 could result in increased levels of this cytokine. Peripheral blood PMNs obtained from 20
healthy donors were nonactivated or activated with IL-12, IL-15 or IL-18 in different concentrations
and challenged with strain 18 Pb (Pb18) for 2 h, 4 h, 12 h, 24 h and 48 h and evaluated for IFN-c produc-
tion, by ELISA. In other experiments, PMNs were treated with monoclonal antibodies anti-TLR2, TLR4 and
Dectin-1, challenged with Pb and evaluated for IFN-c production. We found that Pb induces human PMNs
to produce IFN-c, probably by binding to TLR4 and Dectin-1 receptors expressed by these cells. Moreover,
IFN-c levels were signiﬁcantly increased when cells were activated with each of the tested cytokines or a
combination of two of them, being the association IL-12 plus IL-15 the most effective. The results support
our hypothesis that during infection by Pb, human PMNs modulate the adaptive immune response to a
Th1 response pattern, via IFN-c production.
 2014 Elsevier Ltd. All rights reserved.1. Introduction
Paracoccidioidomycosis (PCM) is a systemic mycosis endemic in
most Latin American countries, especially in Brazil, whose etiologic
agent is Paracoccidioides brasiliensis (P. brasiliensis), a thermodimor-
phic fungus. Infectious agents are fungal mycelium propaguleswhich live in the soil and penetrate the host through the respira-
tory tract, reaching the alveoli of the lung [1]. Many people are
exposed to the fungus, but only a small number develop clinical
symptoms, suggesting that both innate and adaptive mechanisms
are important to fungus clearance [2,3].
During innate immune response, phagocytic cells play a critical
role against this fungus with emphasis on participation in fungi-
cidal activity and modulation of the inﬂammatory responses.
Several studies have shown the effector and modulatory functions
of macrophages and monocytes [4–16]. However, studies on neu-
trophils (PMNs), that are the ﬁrst cells recruited to the infection
sites, are scarce. Furthermore, studies to date are related to their
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being reported studies aiming to evaluate the modulatory role of
these cells on both, the innate and adaptative immune response
against this fungus. This role of PMNs deserves further study
because a large number of studies in recent years have shown that
these cells are capable of producing a wide range of different cyto-
kines and other molecules enabling them to play an active role in
the modulation and communication with the immune system [22].
IFN-c is the major cytokine produced during the effector phase
of a Th1 immune response. However, the role of this cytokine in
driving this type of response, during innate immune response,
has also been demonstrated. Trinchieri [23] and Wysocka et al.
[24], showed that the initial synthesis of IFN-c may be required
for the generation of IL-12, essential for Th1 effector cells differen-
tiation. Thus, an initial burst of IFN-c can induces antigen-present-
ing cells to initiate a Th1 response directly or indirectly via
induction of IL-12.
Resistance against P. brasiliensis infection is mediated by a Th1
response [25]. Thus, cells of the innate immune response that is
able to producing this cytokine may instruct the adaptive immune
response toward this pattern. NK (natural killer) cells are the main
cells involved in IFN-c production during the innate immune
response. However, studies have suggested that PMNs may also
constitute important sources of this cytokine [26–31].
Effector and modulatory functions of phagocytic cells, including
neutrophils, are initiated by mechanisms of activation of these
cells induced by microorganism recognition. This process involves
a number of receptors denominated ‘‘pattern-recognition recep-
tors’’ (PRRs), that recognize molecular structures shared by a large
number of microorganisms, termed ‘‘pathogen-associated molecu-
lar patterns’’ (PAMPs). Among the PRRs involved in fungus recogni-
tion are the Toll-like receptors (TLRs) and C-type lectin receptors
[32].
In this study, we asked whether human PMNs, by producing
IFN-c, may instruct adaptative immune response against P. brasil-
iensis toward a Th1 response. The role of the innate immune
response cytokines, such as IL-12, IL-15 and IL-18, was also evalu-
ated as well as the involvement of different PRRs. We found that P.
brasiliensis induces highly puriﬁed human PMNs to produce IFN-c
by binding to TLR4 and Dectin-1 receptors expressed by these cells.
In addition, the levels of the cytokine were signiﬁcantly increased
by PMNs activation with each of the cytokines, but mainly with a
combination of two of them, being IL-12 plus IL-15 the most
effective.2. Materials and methods
2.1. Subjects
Healthy blood donors from University Hospital of the Botucatu
Medical School, São Paulo State University, UNESP, were evaluated
in this study. The study was approved by Ethics Committee of this
School, and informed consent was obtained from all the blood
donors.2.2. Isolation, puriﬁcation and culture of human blood PMNs
Blood was collected and centrifuged at Histopaque solution
containing two density gradients: 1119 and 1083 g/mL (Sigma–
Aldrich) for 29 min, 460 g, 25 C. This Histopaque preparation
allows the separation of two halos of cells: one rich in mononu-
clear and another in polymorphonuclear cells. The polymorphonu-
clear rich halo were collected and washed with culture medium
RPMI 1640 supplemented with 2 mM L-glutamine, 40 lg/mL gen-
tamycin (Sigma–Aldrich) for 10 min, 350 g, 4 C. To further purifyPMNs, cells suspension was submitted to incubation with mono-
clonal antibodies anti-CD16 coupled to magnetic beads (MACS
CD16+ human MicroBeads –Miltenyi Biotec, Kit) and PMNs isolated
by positive selection. Recovery of highly puriﬁed cells was con-
ﬁrmed by phenotyping assays using ﬂow cytometry. Puriﬁed PMNs
suspensions were resuspended in culture medium RPMI 1640
supplemented with 2 mM L-glutamine, 40 lg/mL gentamycin
(Sigma–Aldrich) and 10% fetal bovine serum (LGC Systems) (CTCM:
complete tissue culture medium), adjusted to 1  106 and / or
2  106 PMNs/mL and dispensed into 96 or 24-well ﬂat-bottom
plates with a volume of 100 lL/well and / or 1 mL/well in an con-
stant atmosphere of 5% CO2 at 37 C.
2.3. Cells immunophenotyping by ﬂow cytometry
Cells were transferred to ﬂow cytometry tubes, which were cen-
trifuged for 10 min at 1500 rpm. Supernatant was carefully
removed and cells pellet incubated with anti-human CD11b conju-
gated with PeCy5 (Phycoerythrin), anti-human CD56 conjugated
with FITC (Fluorescein Isothiocyanate) and anti-human CD3 conju-
gated with APC (Allophycocyanin) for 30 min. The cells were also
incubated with isotypes controls marked with the respective ﬂuo-
rochrome. After, cells were washed with isoton, centrifuged, the
supernatant discarded and the labeled cells ﬁxed with 50 lL of ﬁx-
ing solution containing 5% formaldehyde (BD – Becton–Dickinson,
USA) and analyzed for CD11b, CD56 and CD3 expression on a FAC-
SCalibur ﬂow cytometer model (BD – Becton–Dickinson, USA)
using CellQuest software (BD – Becton–Dickinson, USA).
2.4. Fungi
Yeast cells of high virulence P. brasiliensis strain (Pb18) were
used throughout this study. To ensure virulence, the isolate was
used after three serial animal passages. The yeast cells were then
maintained by weekly sub-cultivation in the yeast-form cells in
agar medium GPY (2% glucose, 1% peptone, 0.5% yeast extract
and 2% agar medium GPY at 37 C) and used on the sixth day of cul-
ture. To obtain individual cells, the fungal suspension was homog-
enized with glass beads in a Vortex homogenizer (three cycles of
10 s). Then, cell suspensions were maintained at 37 C for 5 min
for sedimentation of undissolved lumps during stirring. After this
period, the supernatants were collected, and an aliquot used for
counting in Neubauer chamber, using a phase contrast microscope,
followed by adjusting the concentration to 2  104 and / or
4  104 yeast cells/mL. Cells with bright appearance were consid-
ered as viable, since dead cells are black colored. Suspensions with
viability greater than or equal to 90% were used.
2.5. Human PMNs treatments and challenge with P. brasiliensis
In initial experiments, PMNs (2  106/mL) were only challenged
with a suspension of Pb18 (4  104 yeasts cells/mL, 1:50 fungus/
PMN ratio) for 24 or 48 h in an constant atmosphere of 5% CO2 at
37 C. In other, PMNs were challenged with Pb18 in the presence
of IL-12, IL-15 or IL-18 alone, at different concentrations, or combi-
nation of two of these cytokines, for 24 and 48 h. In a third set of
assays, before fungus challenge, cells were submitted a protocol
aiming to block the expression of the receptors TLR2, TLR4 and
or Dectin-1. At ﬁrst, the three receptors were simultaneously
blocked. For this, PMNs (1  106/mL) were incubated with mono-
clonal antibodies: anti-TLR2 (3.5 lg/106 cells – Biolegend), anti-
TLR4 (4 lg/106 cells – Biolegend) and anti-Dectin-1 (3 lg/106 cells
– R&D Systems) for 2 h. In subsequent experiments, we adopted a
scheme in which two receptors were blocked and only one was
available. Thus, some cultures were treated only with monoclonal
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Dectin-1 or with anti-TLR4 and anti-Dectin-1.
In all protocols, after incubation, cultures supernatants were
collected and IFN-c concentrations were evaluated by ELISA,
according to the manufacturer’ instructions (DuoSet Kit – Human
IFN-c – R&D Systems). This DuoSet Kit is calibrated against a highly
puriﬁed E. coli-expressed recombinant human IFN-c. In addition,
suspensions containing recombinant IFN-c from other species than
human were assayed and exhibited no cross-reactivity, comprovat-
ing the speciﬁcity of the kit. Likewise, tipical standard curve can be
obtained with initial concentrations of 10 pg/mL, showing the high
sensitivity of the method.2.6. Intracytoplasmic expression of IFN-c by ﬂow cytometry
PMNs (1  106/mL) were incubated with sets of two cytokines
as follows: IL-12 + IL-15 or IL-12 + IL-18 or IL-15 + IL-18, chal-
lenged with Pb18 (2  104 yeasts cells/mL, 1:50 fungus/PMN ratio)
and maintained for 24 h in an constant atmosphere of 5% CO2 at
37 C. Six hours before the end of cultivation, cultures were treated
with brefeldin A solution (1.000 – 5 mg/mL) to prevent the
release of cytokines from cell cytoplasm. After the end of culture,
supernatants were removed, the cultures collected and transferred
to ﬂow cytometry tubes (Falcon BD – Becton–Dickinson, USA),
which were centrifuged for 10 min at 1500 rpm. Supernatant was
carefully removed and cells pellet were resuspended in 100 lL of
the solution A of the permeabilization kit Fix & Perm (Bio Research,
ADG), incubated at room temperature in the dark for 15 min and
centrifuged. The supernatants were then carefully removed and
cells pellet resuspended in 100 lL of the solution B of the same
permeabilization kit in the presence of conjugated anti-human
IFN-c with PE (Phycoerytrin – BioLegend) for 15 min in the dark.
The cells were also incubated with isotype control monoclonal
antibody marked with the respective ﬂuorochrome. Subsequently,
the cells were washed with ISOTON, centrifuged, the supernatant
discarded and the labeled cells ﬁxed with 50 lL of ﬁxing solution
containing 5% formaldehyde (BD – Becton–Dickinson, USA) and
analyzed for intracytoplasmic expression of IFN-c by ﬂow cytome-
try. Analyses were performed on FACSCalibur ﬂow cytometer
model (BD – Becton–Dickinson, USA) using CellQuest software
(BD – Becton–Dickinson, USA).2.7. Statistical analysis
Statistical analysis was performed by using the GraPhpad Prism
Version 5.01 for Windows, GraphPad Software, Inc., (San Diego,
California – USA). Signiﬁcant differences among groups were deter-
mined by analysis of variance test for dependent samples, and the
averages compared by Multiple Correlations Tukey–Kramer test,
assuming as true every case in which the probability of error was
less than 5% (p < 0.05).Fig. 1. Cells immunophenotyping by ﬂow cytometry showing the purity of isolated PMNs
CD56 and CD3, conjugated with PECy5, FITC and APC, respectively, and evaluated by ﬂow
relative to expression of CD11b, CD56 and CD3, respectively, and no shaded to isotype-3. Results
3.1. Evaluation of IFN-c production by human PMNs challenged with
Pb18
In a ﬁrst set of experiments, immunophenotyping by ﬂow
cytometry conﬁrmed the purity of the isolated PMNs. The presence
of contaminating cells such as NK and T, which are potentially pro-
ducers of IFN-c, was tested. Fig. 1A shows the expression of CD11b,
a typical marker of PMNs, but absence of CD56 (Fig. 1B) and CD3
(Fig. 1C) markers of NK cells and T lymphocytes, respectively. After
assuring PMNs purity, we asked whether no activated PMNs have
the capacity to release IFN-c in response to Pb18 (Fig. 2). Of inter-
est, unchallenged PMNs did not produce detectable concentrations
of IFN-c at all periods of evaluation. However, cytokine production
was detected after Pb challenge. Higher levels was produced at
48 h and mainly at 24 h in which the results were statiscally differ-
ent in relation to other periods.
Based on these results the subsequent experiments were per-
formed at 24 and 48 h after cells challenge with the fungus.
3.2. Involvement of TLR2, TLR4 and Dectin-1 in IFN-c production by
human PMNs
After detecting that P. brasiliensis induces IFN-c production by
PMNs, we aimed to evaluate the role of TLR2, TLR4 and Dectin-1
in this production. In both periods (24 and 48 h) in cultures in
which the three receptors have been blocked, we found a signiﬁ-
cant decrease in cytokine production as compared to cultures chal-
lenged with the fungus, but not blocked. These results suggested
the involvement of at least one of the tested receptors in cytokine
production. In subsequent cultures, the involvement of each recep-
tor was tested. For this purpose, cultures were performed in which
one receptor has become available and the other two were blocked.
When TLR2 was available, but Dectin-1 and TLR4 were blocked, the
production of IFN-c was slightly reduced compared to that
obtained in cultures without any blockage, suggesting no involve-
ment of this receptor. On the other hand, especially at 48 h, in
experiments in which Dectin-1 or TLR4 was available, the highest
levels of IFN-c were detected, showing the involvement of both
receptors in cytokine production (Fig. 3).
3.3. Evaluation of IFN-c production by human PMNs activated with
IL-12, IL-15 and IL-18 before challenge with Pb18
In our next experiments we tested whether activation with
IL-12, IL-15 and IL-18 could modulate IFN-c production by PMNs
in response to the fungus. Fig. 4A–C show the results of the
experiments performed for choosing the best concentrations of
the cytokines. PMNs were incubated for 24 and 48 h with IL-12,
IL-15 or IL-18 in the concentrations of 5, 10, 20, 50 and 100 ng/mL.
We detected that the three cytokines signiﬁcantly increase. Cells (1  106/mL) were incubated with monoclonal antibodies anti-human CD11b,
cytometry. Shaded histograms in (A), (B) and (C) show the intensity of ﬂuorescence
control staining.
Fig. 2. IFN-c production by human PMNs (2  106/mL) challenged with Pb18
(4  104 yeasts/mL: 1:50 fungus/PMN ratio) for 2, 4, 12, 24 and 48 h and evaluated
by ELISA. The results are expressed in mean ± SD of experiments performed with
cells from 4 subjects. Statistically signiﬁcant differences between groups are
indicated. *p < 0.05 vs. 2, 4 and 12 h.
Fig. 3. Involvement of TLR2, TLR4 and Dectin-1 on IFN-c production by human
PMNs. Cells (1  106/mL) were incubated with anti-TLR2, anti-TLR4 and/or anti-
Dectin-1 monoclonal antibodies for 2 h, challenged with Pb18 (2  104 yeasts/mL:
1:50 fungus/PMN ratio) for 24 h and 48 h and evaluated for IFN-c production, by
ELISA. The results are expressed in mean ± SD of experiments performed with cells
obtained from 7 subjects. Statistically signiﬁcant differences between groups are
indicated. *p < 0.001; #p < 0.05 vs. other cultures in the same period.
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10 and 20 ng/mL and for IL-15 and IL-18 were 50 and 100 ng/mL.
These concentrations were used to test the effect of these cytokines
on IFN-c production by PMNs in response to the fungus. The
results are shown in (Fig. 5). IL-12 signiﬁcantly increased IFN-c
production by PMNs in response to the fungus. The best results
were obtained with 10 ng/mL at 24 h and 20 ng/mL at 48 h.
Activation with IL-15 also resulted in cytokine increase, but the
results were not signiﬁcant. In relation to IL-18 a signiﬁcant
increase was detected at 24 h with the concentration of 100 ng/mL.
3.4. Evaluation of IFN-c production by human PMNs treated with
combinations of IL-12, IL-15 and IL-18 and challenged with Pb18
After detecting that each of the cytokines alone induces
increased production of IFN-c, we evaluated whether activation
of cells with a combination of two cytokines resulted in a synergis-
tic effect on this production. Fig. 6A–C show the results for theproduction of IFN-c by PMNs cultures treated with the following
sets of cytokines: (A) IL-12 + IL-15 or (B) IL-12 + IL-18 or (C)
IL-15 + IL-18. For the duo set IL-12 and IL-15 the best results were
obtained at 48 h and with the concentrations of 10 ng/mL and
100 ng/mL respectively, in which the mean of the obtained concen-
trations was 722 pg/mL. With the set formed by IL-12 and IL-18
similar results were obtained at 24 and 48 h. The best concentra-
tions were 20 ng/mL and 100 ng/mL for IL-12 and IL-18, respec-
tively (Mean = 392 pg/mL). In relation to IL-15 + IL-18 the best
results were obtained at 48 h and with 50 ng/mL and 100 ng/mL
respectively, in which the mean value was 290 pg/mL. The results
make it clear that the 3 sets of two cytokines induced a signiﬁcant
increase in IFN-c production compared to each cytokine alone,
since the maximum values obtained for IL-12, IL-15 and IL-18 indi-
vidually were 42 pg/mL, 26 pg/mL and 50 pg/mL, respectively. In
addition, it should be noted that the results obtained with IL-12
plus IL-15 were signiﬁcantly higher than those found with the
other sets of two cytokines.3.5. Intracytoplasmic expression of IFN-c by human PMNs activated
with IL-12, IL-15 and IL-18 and challenged with Pb18, by ﬂow
cytometry
As the production of IFN-c by human PMNs is still considered a
controversial issue in the literature, we decided to conﬁrm the abil-
ity of these cells to produce this cytokine, using one methodology
complementary to ELISA. Therefore, we chose to evaluate the intra-
cytoplasmic expression of IFN-c, by ﬂow cytometry. For this assay
we used the 3 sets of two cytokines that were shown to induce bet-
ter results in ELISA. All the treatments induced an increase in the
percentage of cells that expressed the cytokine (Fig. 7A) as well
as in the intensity of ﬂuorescence (Fig. 7B). However, similarly to
the results detected by ELISA, the combination of IL-12 plus IL-15
showed the best results.4. Discussion
In recent years, PMNs have been considered as potent immuno-
modulatory cells due to their ability to produce various molecules
including important pro and anti-inﬂammatory cytokines. Here,
we aimed to assess whether human PMNs can instruct the adap-
tive immune response against P. brasiliensis toward a protective
pattern, which involves Th1 cells, by the production of IFN-c.
A ﬁrst important point of discussion is relative to purity of our
culture, since other cells than PMNs, such as NK and lymphocytes
could be responsible for IFN-c production. Some procedures dis-
carded this possibility. First, we obtained a halo rich in polimor-
phonuclear cells by using a Histopaque with two density
gradients. After, PMNs were separated by using monoclonal anti-
bodies anti-CD16, a molecule present in the surface of these cells.
For this, we used a kit of positive magnetic selection in which CD16
positive cells bind to monoclonal antibodies against this molecule
which, in turn, are coupled to magnetic beads. In addition, cells
immunophenotyping by ﬂow cytometry conﬁrmed that culture
cells did not show substantial expression of typical markers of
NK cells and lymphocytes. In addition, some CD56 CD16+ NK cells
which might be present in the culture are weak producers of IFN-c
and possibly have not contribute to the production of this cytokine.
We found that no activated PMNs have the capacity to produce
low IFN-c levels in response to challenge with Pb18. Moreover,
TLR4 and Dectin-1 may be the receptors involved in this produc-
tion, while TLR2, in contrast, appears to participate in the mecha-
nisms of inhibition of this process, since when it has been
blocked an increased production of the cytokine was detected.
Fig. 4. Effect of IL-12 (A), IL-15 (B) and IL-18 (C) on IFN-c production by human PMNs. Cells (2  106/mL) were incubated with different concentrations of IL-12, IL-15 and
IL-18 (5, 10, 20, 50 and 100 ng/mL) for 24 h and 48 h and evaluated for IFN-c production by ELISA. The results are expressed in mean ± SD of experiments performed with cells
obtained from 4 subjects. Statistically signiﬁcant differences between groups are indicated. *p < 0.001, #p < 0.005 vs. respective no activated PMNs.
Fig. 5. Effect of IL-12, IL-15 and IL-18 on IFN-c production by human PMNs in
response to P. brasiliensis. PMNs (2  106/mL) were challenged with Pb18 (4  104
yeasts/mL: 1:50 fungus/PMN ratio) for 24 h and 48 h in the presence of the best
concentrations of IL-12 (10 and 20 ng/mL), IL-15 (50 and 100 ng/mL) and IL-18 (50
and 100 ng/mL) and evaluated for IFN-c production by ELISA. The results are
expressed in mean ± SD of experiments performed with cells obtained from 4
subjects. Statistically signiﬁcant differences between groups are indicated. *p < 0.05
vs. PMNs + Pb18 without cytokine treatment in the respective period.
106 D.R. Rodrigues et al. / Cytokine 69 (2014) 102–109There are no studies showing which PRRs are involved in the
production of IFN-c by human PMNs and particularly in response
to pathogenic fungi. Thus, for discussing the actual role of these
receptors, previous data obtained in paracoccidioidomycosis and
in other fungal infections, using other in vivo and in vitro experi-
mental protocols, will be considered. Our results strongly suggest
that binding of P. brasiliensis to both TLR4 and Dectin-1 results in
protection, whereas in contrast TLR2 is involved in pathogenicity.
However, this reasoning is only partially supported by the litera-
ture, which reﬂects the complexity of the interactions Pb/PRRs.
Calich et al. [33], showed that both TLR2 and TLR4 are involved
in the recognition of the fungus, increase in phagocytic ability ofinfected macrophages and NO secretion. However, this process
did not result in efﬁcient macrophage activity and signiﬁcant
reduction in fungal load, which lead the author to consider that
both receptors are involved in virulence mechanisms. Accordingly,
in susceptible animals, the differentiation of regulatory dendritic
cells (DCs) that secrete high levels of IL-10 and low IL-12 occurs
via activation of TLR2 [34]. On the other hand, TLR2 was shown
to play a protective role during the lung infection with P. brasilien-
sis, since this receptor negatively controls exacerbated inﬂamma-
tory response mediated by Th17, which is highly deleterious to
the lung tissue. Likewise, TLR4 signaling mechanisms also lead to
severe lung infection associated with pró-inﬂammatory response
induced by Th17 and reduction of regulatory T cells [35,36].
Speciﬁcally in relation to human PMNs, previous studies in our
laboratory suggested that the interaction of the fungus with TLR2
and TLR4 can be considered a pathogenic mechanism, since this
fungus uses these two receptors for its entry into cells and escape
from their effector functions, through the production of IL-8 and
IL-10 [37]. Comparing these results with those obtained in the
present study we can suggest that fungus binding to the same
PRR in PMNs can trigger both pro and anti-inﬂammatory
responses. For example, Pb18 binding to TLR4 lead PMNs to pro-
duce IFN-c as detected in this study, as well as IL-10, reported
previously.
Studies focusing on Dectin-1 have shown that this receptor
seems to play different roles in a dependence of fungal species
[38]. In paracoccidioidomycosis these studies are scarce, but our
results strongly suggest its involvement in protection mechanisms.
Cytokines production by phagocytic cells in response to micro-
organisms can be modulated by several factors, including other
cytokines released by the cells themselves [39–42]. Accordingly,
cytokines released during innate immune response such as IL-12,
IL-15 and IL-18 alone or in combination are extremely important
in this process. The present study has demonstrated that PMNs
incubation with each of these cytokines in optimum concentra-
tions and periods, during the challenge with P. brasiliensis, result
in a signiﬁcant increase in the production of IFN-c. However, better
Fig. 6. Effect of sets of two cytokines on IFN-c production by human PMNs in response to P. brasiliensis. PMNs (2  106/mL) were challenged with Pb18 (4  104 yeasts/mL:
1:50 fungus/PMN ratio) for 24 h and 48 h in the presence of (A) IL-12 + IL-15 or (B) IL-12 + IL-18 or (C) IL-15 + IL-18 in different concentrations and evaluated for IFN-c
production by ELISA. The results are expressed in mean ± SD of experiments performed with cells from 4 subjects. Statistically signiﬁcant differences between groups are
indicated. *p < 0.05 vs. PMNs + Pb18 without cytokine treatment in the respective period.
Fig. 7. Intracytoplasmic expression of IFN-c by PMNs. Cells (1 106/mL) were challenged with Pb18 (2 104 yeasts/mL: 1:50 fungus/PMN ratio) in the presence of IL-12 + IL-15,
or IL-12 + IL-18 or IL-15 + IL-18 for 24 h and evaluated for intracytoplasmic expression of IFN-c. (A) Percentage of cells expressing the cytokine and (B) median of the intensity
of ﬂuorescence (MIF). The results are expressed in mean ± SD of the experiments performed with cells from 4 subjects. Statistically signiﬁcant differences between groups are
indicated. *p < 0.05 vs. PMNs + Pb18 without cytokine.
D.R. Rodrigues et al. / Cytokine 69 (2014) 102–109 107results were obtained by using combinations of two cytokines. The
highest production was detected after incubation with IL-12 plus
IL-15. Ethuin et al. [43], demonstrated that human PMNs may con-
tain a small stock of IFN-c, but these cells may also synthesize and
release this cytokine in response to LPS after stimulation with IL-12
in combination with IL-2, IL-15 and IL-18. However, as detected
here, the combination of IL-12 + IL-15 seems to be the most
efﬁcient.Together, the results showed that P. brasiliensis binding to PMNs
via TLR4 and Dectin-1 induced these cells to produce IFN-c and
that this production is positively modulated by cytokines, particu-
larly IL-12 + IL-15. These ﬁndings corroborate our hypothesis that
during infection with P. brasiliensis, PMNs may modulate the adap-
tive immune response toward a protective response mediated by
Th1 cells. These results are supported by studies in other infec-
tions. Yin and Ferguson [44], demonstrated that IFN-c plays a
108 D.R. Rodrigues et al. / Cytokine 69 (2014) 102–109crucial role in the immune response during infection with Listeria
monocytogenes and that besides NK cells, PMNs are important
sources of this cytokine. In a study with Nocardia asteroides great
number of PMNs, in the early phase of infection, was associated
with high levels of IFN-c [45].
Although our main objective was to test whether PMNs could
modulate adaptative immune response against P. brasiliensis, the
ﬁnding that these cells are able to producing IFN-c, may also have
great implications in innate immune response modulation. During
this response when PMNs are numerous, IFN-c release by these
cells may, in an autocrine way, regulate the antifungal functions
of them and other cells, such as macrophages. Among the functions
increased after cells activation with IFN-c are: oxidative burst,
migration, apoptosis and production of other activator cytokines
such as TNF-a [46–48]. This mechanism is particularly important
in paracoccidioidomycosis, since the role of these cytokines has
been demonstrated in the activation of monocytes, macrophages
and PMNs for these cells present fungicidal activity [4–16,20].
Overall, our results support the literature data proving increas-
ingly that PMNs can play an active role in modulating and commu-
nicating with the immune system [45]. Given that PMNs are often
the ﬁrst cells to respond to infection, they could have a pivotal role
in the early steps of the inﬂammatory process, in order to drive host
immune response to a resistance or susceptibility pattern. Of note,
our study detected that this process may occur during the course
of paracoccidioidomycosis. Future studies should be directed to a
better understanding of this process in order to consider PMNs as
a valuable therapeutic target in paracoccidioidomycosis.Acknowledgements
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